Literature DB >> 30030003

Physiologic functions of PP2A: Lessons from genetically modified mice.

Sara Reynhout1, Veerle Janssens2.   

Abstract

Protein Phosphatase 2A (PP2A) encompasses a large family of Ser/Thr phosphatases, consisting of a catalytic C subunit and a structural A subunit that are, in most cases, further bound to a regulatory B-type subunit. The B-type subunits determine function and regulation of PP2A trimers, but despite their importance in PP2A biology, their roles in controlling dephosphorylation of a given substrate in a given cell or tissue remain poorly defined, particularly in the context of a complete organism. Besides twenty PP2A subunit encoding genes, some of which are tissue-specifically expressed, five additional genes encode major regulators of active PP2A trimer assembly, and at least seven genes encode cellular PP2A inhibitors, further adding to the complexity of the mammalian PP2A system. In this review, we summarize current knowledge on physiologic functions of PP2A in germ cell maturation, embryonic development, metabolic regulation, tumor suppression, and homeostasis of adult brain, heart, liver, immune system, lung, intestine, kidney, skin, bone and eye, all retrieved from in vivo studies using PP2A transgenic, knockout or knockin mice. Data from 63 mouse models, generated between 1998 and now, reveal the essentiality of PP2A in vivo, and shed light on tissue-specific functions of particular PP2A subunits on the one hand, and functional redundancies on the other hand. In future, it remains of utmost importance to further characterize the existing models, as well as to generate novel models, with the aim of deepening our insights in PP2A (patho)physiology and, particularly, in the therapeutic potential of PP2A targeting in human disease.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac dysfunction; Genetically modified mouse models; Hematopoiesis and immune system dysfunction; Lipid and glucose metabolism; Protein Phosphatase 2A (PP2A); Tauopathy; Tumor suppressor

Mesh:

Substances:

Year:  2018        PMID: 30030003     DOI: 10.1016/j.bbamcr.2018.07.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  30 in total

1.  Benzene-induced mouse hematotoxicity is regulated by a protein phosphatase 2A complex that stimulates transcription of cytochrome P4502E1.

Authors:  Liping Chen; Ping Guo; Haiyan Zhang; Wenxue Li; Chen Gao; Zhenlie Huang; Junling Fan; Yuling Zhang; Xue Li; Xiaoling Liu; Fangping Wang; Shan Wang; Qingye Li; Zhini He; Huiyao Li; Shen Chen; Xiaonen Wu; Lizhu Ye; Qiong Li; Huanwen Tang; Qing Wang; Guanghui Dong; Yongmei Xiao; Wen Chen; Daochuan Li
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

Review 2.  Non-redox cycling mechanisms of oxidative stress induced by PM metals.

Authors:  James M Samet; Hao Chen; Edward R Pennington; Philip A Bromberg
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

3.  Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance.

Authors:  Muayad Al-Badrani; Punnag Saha; Ayan Mondal; Ratanesh K Seth; Sutapa Sarkar; Diana Kimono; Dipro Bose; Dwayne E Porter; Geoff I Scott; Bryan Brooks; Samir Raychoudhury; Mitzi Nagarkatti; Prakash Nagarkatti; Saurabh Chatterjee
Journal:  Environ Toxicol Pharmacol       Date:  2020-07-17       Impact factor: 4.860

4.  Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.

Authors:  Muayad Albadrani; Ratanesh K Seth; Sutapa Sarkar; Diana Kimono; Ayan Mondal; Dipro Bose; Dwayne E Porter; Geoff I Scott; Bryan Brooks; Samir Raychoudhury; Mitzi Nagarkatti; Prakash Nagarkatti; Yvon Jule; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-08       Impact factor: 4.052

5.  Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent.

Authors:  Ayan Mondal; Punnag Saha; Dipro Bose; Somdatta Chatterjee; Ratanesh K Seth; Shuo Xiao; Dwayne E Porter; Bryan W Brooks; Geoff I Scott; Mitzi Nagarkatti; Prakash Nagarkatti; Saurabh Chatterjee
Journal:  Toxicology       Date:  2021-08-17       Impact factor: 4.571

6.  Differential Proteomic Analysis of Hepatocellular Carcinomas from Ppp2r5d Knockout Mice and Normal (Knockout) Livers.

Authors:  Caroline Lambrecht; Gabriela Bomfim Ferreira; Judit DomÈnech Omella; Louis Libbrecht; Rita DE Vos; Rita Derua; Chantal Mathieu; Lut Overbergh; Etienne Waelkens; Veerle Janssens
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

7.  De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.

Authors:  Sara Reynhout; Sandra Jansen; Dorien Haesen; Siska van Belle; Sonja A de Munnik; Ernie M H F Bongers; Jolanda H Schieving; Carlo Marcelis; Jeanne Amiel; Marlène Rio; Heather Mclaughlin; Roger Ladda; Susan Sell; Marjolein Kriek; Cacha M P C D Peeters-Scholte; Paulien A Terhal; Koen L van Gassen; Nienke Verbeek; Sonja Henry; Jessica Scott Schwoerer; Saleem Malik; Nicole Revencu; Carlos R Ferreira; Ellen Macnamara; Hilde M H Braakman; Elise Brimble; Maura R Z Ruzhnikov; Matias Wagner; Philip Harrer; Dagmar Wieczorek; Alma Kuechler; Barak Tziperman; Ortal Barel; Bert B A de Vries; Christopher T Gordon; Veerle Janssens; Lisenka E L M Vissers
Journal:  Am J Hum Genet       Date:  2018-12-27       Impact factor: 11.025

8.  Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1β Production.

Authors:  Marwa Qadri; Sandy ElSayed; Khaled A Elsaid
Journal:  J Pharmacol Exp Ther       Date:  2020-11-25       Impact factor: 4.030

9.  Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.

Authors:  Tamara Mirzapoiazova; Gang Xiao; Bolot Mambetsariev; Mohd W Nasser; Emily Miaou; Sharad S Singhal; Saumya Srivastava; Isa Mambetsariev; Michael S Nelson; Arin Nam; Amita Behal; Leonidas Arvanitis; Pranita Atri; Markus Muschen; François L H Tissot; James Miser; John S Kovach; Martin Sattler; Surinder K Batra; Prakash Kulkarni; Ravi Salgia
Journal:  Mol Cancer Ther       Date:  2021-07-12       Impact factor: 6.261

10.  PP2A in LepR+ mesenchymal stem cells contributes to embryonic and postnatal endochondral ossification through Runx2 dephosphorylation.

Authors:  Yu-Ting Yen; May Chien; Pei-Yi Wu; Shih-Chieh Hung
Journal:  Commun Biol       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.